Canigen DHPPi inj. susp. (lyoph. + solv.) s.c. vial

Země: Belgie

Jazyk: angličtina

Zdroj: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Aktivní složka:

Canine Adenovirus 2 (live, attenuated) ; Canine Distemper Virus (live, attenuated) ; Canine Parainfluenzavirus (live, attenuated) ; Canine Parvovirus (live, attenuated)

Dostupné s:

Virbac S.A.

ATC kód:

QI07AD04

INN (Mezinárodní Name):

Canine Adenovirus Type 2; Canine Parainfluenza Virus; Canine Distemper Virus (CDV); Canine Parvovirus

Léková forma:

Lyophilisate and solvent for suspension for injection

Složení:

Canine Adenovirus Type 2; Canine Parainfluenza Virus; Canine Distemper Virus (CDV); Canine Parvovirus

Podání:

Subcutaneous use

Terapeutické skupiny:

dog

Terapeutické oblasti:

Canine Distemper Virus + Canine Adenovirus + Canine Parvovirus + Canine Parainfluenza Virus

Přehled produktů:

CTI code: 501733-05 - Pack size: 50 x 1 ml + 50 x 1 dose - Commercialisation status: YES - Delivery mode: Medical prescription; CTI code: 501733-04 - Pack size: 25 x 1 dose + 25 x 1 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 501733-06 - Pack size: 100 x 1 dose + 100 x 1 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 501733-01 - Pack size: 1 dose + 1 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 501733-03 - Pack size: 10 x 1 ml + 10 x 1 dose - Commercialisation status: YES - Delivery mode: Medical prescription; CTI code: 501733-02 - Pack size: 5 x 1 ml + 5 x 1 dose - Commercialisation status: NO - Delivery mode: Medical prescription

Stav Autorizace:

Commercialised: Yes

Datum autorizace:

2016-10-06